Impairment of the beta-adrenergic system of peripheral-blood leukocytes in atopic patients with seasonal allergic rhinoconjunctivitis

URN to cite this document:

urn:nbn:de:bvb:355-epub-197891 Copy

DOI to cite this document:

10.5283/epub.19789 Copy

Haen, Ekkehard ; Bleise, Ute ; Przybilla, W.

Preview

PDF (712kB)

Date of publication of this fulltext: 11 Mar 2011 06:40

---

Details

Item type:	Article
Journal or Publication Title:	International Archives of Allergy and Immunology
Publisher:	Karger
Volume:	99
Number of Issue or Book Chapter:	2-4
Page Range:	pp. 435-438
Date:	1992
Institutions:	Medicine > Lehrstuhl für Psychiatrie und Psychotherapie
Dewey Decimal Classification:	500 Science > 500 Natural sciences & mathematics
Status:	Published
Refereed:	Unknown
Created at the University of Regensburg:	Unknown
Item ID:	19789

Preview

Export bibliographical data

ASCII CitationAtomBibTeXData Cite XMLDataCite XML OAIDublin CoreEndNoteHTML CitationJSON LDMETSMODSOpenAPCRDF+N-TriplesRDF+N3RDF+XMLReferReference ManagerSimple MetadataXMLxMetaDissPlus

---

Abstract

Compared to 7 healthy women, an altered beta2-adrenoceptor/cyclic adenosine monophosphate (cAMP) system has been observed in a combined study on both expression and function of beta2-adrenoceptors on peripheral blood leukocytes (PBL) of 7 atopic women suffering from acute seasonal rhinoconjunctivitis. A reduced affinity of the beta-adrenergic radioligand I-125 cyanopindolol to its binding site ...

Abstract

Compared to 7 healthy women, an altered beta2-adrenoceptor/cyclic adenosine monophosphate (cAMP) system has been observed in a combined study on both expression and function of beta2-adrenoceptors on peripheral blood leukocytes (PBL) of 7 atopic women suffering from acute seasonal rhinoconjunctivitis. A reduced affinity of the beta-adrenergic radioligand I-125 cyanopindolol to its binding site (equilibrium dissociation constant K(d) 6.4+/- 1.0 vs. 3.4 +/-0.6 pmol/l in controls; p < 0.05), a reduced sensitivity of the intracellular cAMP formation to isoprenaline (concentration necessary to achieve half-maximal effectiveness EC50 1,088.6 +/- 669.0 vs. 71.0 +/- 51.0 nmol/l in controls; p<0.01), and a reduced intracellular cAMP increase in response to isoprenaline (E(max) as a percentage of the basal cAMP content E0 117 +/- 3 vs. 145 +/- 8% E0 in controls; p<0.01) point to a subsensitivity of beta2-adrenoceptors. A reduced E0 (4.9 +/- 0.8 vs. 8.4 +/- 1.3 pmol/10(6) cells in controls; p< 0.05) suggests an increased activity of the cAMP-degrading enzyme phosphodiesterase. A reduced sympathetic tone in atopy was further confirmed by lower cAMP plasma concentrations (25.7 +/- 1.2 vs. 31.3 +/- 1.6 nmol/l in controls; p<0.05). The results indicate that more than just one mechanism are involved in the impairment of the PBL beta2-adrenoceptor/cAMP system in atopy.

---

---

Metadata last modified: 26 Nov 2020 07:28

Owner only: item control page

Download Statistics

Download Statistics

Download Statistics

Download Statistics

Downloads

Downloads per month over past year

More literature (via CORE)

More literature (via CORE)

More literature (via CORE)

More literature (via CORE)